Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Stefaan Vancayzeele"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract We assessed the real-world effectiveness of sacubitril/valsartan in patients with chronic heart failure (HF) and reduced ejection fraction (HFrEF) with an emphasis on those with older age (≥ 75 years) or with New York Heart Association (NY
Externí odkaz:
https://doaj.org/article/39c891947987435196a70a0075c976ec
Autor:
Renaud Louis, Charles Pilette, Olivier Michel, Alain Michils, Guy Brusselle, Antoine Poskin, Jan Van Schoor, Kris Denhaerynck, Stefaan Vancayzeele, Ivo Abraham, Sandra Gurdain
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 15, Iss 1, Pp 1-9 (2019)
Abstract Background Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgEtot) in asthmatics remains poorly documented.
Externí odkaz:
https://doaj.org/article/7a4af88e2e29494bb8a7b297e43013c6
Autor:
Ivo Abraham, Heidi Brié, Nimer Alkhatib, Kris Denhaerynck, Stefaan Vancayzeele, Karen MacDonald, Dina Hamarneh
Publikováno v:
Current Medical Research and Opinion. 37:367-375
Seven prospective real-world studies conducted in general practices in Belgium of antihypertensive treatment with valsartan-centric regimens were pooled to examine similarities and differences in determinants of blood pressure (BP) values (mmHg) and
Autor:
Alain Michils, Kris Denhaerynck, Stefaan Vancayzeele, Guy Brusselle, Antoine Poskin, Charles Pilette, Ivo Abraham, Jan Van Schoor, Sandra Gurdain, Olivier Michel, Renaud Louis
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 15, Iss 1, Pp 1-9 (2019)
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY
Allergy, asthma, and clinical immunology, 15
Allergy, asthma, and clinical immunology, Vol. 15, no.1, p. 20 [1-9] (2019)
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY
Allergy, asthma, and clinical immunology, 15
Allergy, asthma, and clinical immunology, Vol. 15, no.1, p. 20 [1-9] (2019)
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Immunoglobulin E (IgE) is the treatment target of omalizumab, a monoclonal antibody indicated in the treatment of severe allergic asthma. Long-term variability of serum total IgE (sIgEtot) in asthmatics remains poorly documented.
SCOPUS: ar.j
SCOPUS: ar.j
Autor:
Stefaan Vancayzeele, L Villa, Diana Sun, Yoleen Van Camp, Nimer S. Alkhatib, Heidi Brié, Dina Hamarneh, Kris Denhaerynck, Karen MacDonald, Ivo Abraham
Publikováno v:
Current medical research and opinion
Aims Six prospective real-world studies of antihypertensive treatment with valsartan-centric regimens were pooled to: (1) examine the effectiveness of similar to 90 days of second- or later-line valsartan treatment in hypertensive patients with known
Publikováno v:
Allergy and immunology.
Background: In patients with a diagnosis of asthma, there is currently no consensus which allergy tests should be performed to confirm a diagnosis of allergy. Aims and Objectives: We aimed to gain insight in the decision making in allergy testing in
Publikováno v:
Allergy and immunology.
Background: In patients with asthma, there is currently no clear consensus which tests should be performed to confirm a diagnosis of allergy. Aims and Objectives: We aimed to gain insights in the decision making in allergy testing in patients with as
Autor:
Rebeca Quintana, P. Vo, Leen Tobback, Veruska Carboni, Stefaan Vancayzeele, Mieke Jansen, Evelyne Vanvlasselaer
Publikováno v:
Frontiers in Neuroscience. 12
Autor:
Ivo Abraham, Ann Aerts, Stefaan Vancayzeele, Michael Levengood, L Villa, Karen MacDonald, Diana Sun, Kris Denhaerynck, Heidi Brié, Christine Hermans
Publikováno v:
British Journal of General Practice. 65:e9-e15
Patient adherence is often not monitored because existing methods of evaluating adherence are either burdensome or do not accurately predict treatment outcomes.To examine whether two simple, single-item physician-administered measures of patient adhe
Autor:
Eline Van Craeyveld, Julie Jacob, Anita Leys, Stefaan Vancayzeele, Karen MacDonald, Laurent Levecq, Ivo Abraham, Heidi Brié, Kris Denhaerynck, Filip Mergaerts
Publikováno v:
International Journal of Ophthalmology, Vol. 10, no. 1, p. 81-90 (2017)
AIM: To evaluate the outcomes of ≥6y ranibizumab therapy in neovascular age-related macular degeneration (AMD). METHODS: HELIX was a retrospective, observational effectiveness study using medical records of patients treated in three clinics in Belg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e1864fcacc3f26475920092373cef8
https://hdl.handle.net/2078.1/182110
https://hdl.handle.net/2078.1/182110